Sol Carriazo, Neph.

MD, PhD| Nephrologist| Hereditary Kidney Disease Fellow-UHN| IMS UofTo| ADPKD| AI in Med| @GlomCon educator| @GlomConILA| 🇨🇴🇪🇸🇨🇦🌐

[GlomCon Ibero-LatinoAmérica @GlomConILA]

🚨No te pierdas este sábado el seminario:

☞ El rol de la microscopía electrónica en el diagnóstico de las glomerulopatías 🔬

🗓️ 6/junio/26
🗣️ Dra. Fernanda Toniolo 🇦🇷
🕘 9 am CDMX

Zoom ID: 863 6358 3637
Pass: 343 190

#GlomConAmor #GlomConILA

[Mónica Furlano @m_furlano]

🧬#ADPKD is far more than a #KidneyDisease🧬
It may represent a #systemicvasculopathy driven by #polycystin dysfunction and impaired vascular integrity.
🤔Implications: higher suspicion for acute chest/abdominal pain
https://t.co/gsWYoWZnt8

[GlomCon Ibero-LatinoAmérica @GlomConILA]

🚨No te pierdas este sábado el seminario:

☞ Síndrome Riñón-Pulmón
🗣️ Dra. Diana Carolina Vargas 🇨🇴

🗓️23/Mayo/26
🕘9 am CDMX

Zoom ID: 863 6358 3637
Pass: 343 190

#GlomConAmor #GlomConILA

[Sol Carriazo, Neph. @Nefrontera]

@fouadchebib It looks like a fantastic conference!👏🏽 I hope I can attend in person!

[Sol Carriazo, Neph. @Nefrontera]

Measuring the Impact of tolvaptan-induced polyuria on quality of life in patients with autosomal dominant polycystic kidney disease

[Hans-Joachim Anders @hjanders_hans]

Now open access in @NDTsocial

Tolvaptan-induced polyuria and QoL in pts with ADPKD

🧐 This new questionnaire captures the physical, mental, and social burden of tolvaptan-induced polyuria, and provides a reliable PROM for clinical care and research

▶️https://t.co/8f4tp6yiP5

[Sol Carriazo, Neph. @Nefrontera]

@kidneymo @SalemAlmaani @CSNSCN @ArennJauhal lol the paparazza! @SalemAlmaani Congratulations for the great talk!👏🏽

[GlomCon Ibero-LatinoAmérica @GlomConILA]

🚨No te pierdas este sábado el seminario:

☞ Lo nuevo de LRA en KDIGO: volumen, fluidos y HRS-AKI

🗓️ 9/Mayo/26
🗣️ Dr. Hector Antonio Navarrete 🇲🇽
🕘 9 am CDMX

Zoom ID: 863 6358 3637
Pass: 343 190

#GlomConAmor #GlomConILA

[Hans-Joachim Anders @hjanders_hans]

Now open access in @NDTsocial

KDIGO 2025 ADPKD Guideline: a commentary on intracranial aneurysms and other vascular manifestations from the ERA Working Group Genes & Kidney

▶️https://t.co/gWxv6wrJXW

[Sol Carriazo, Neph. @Nefrontera]

@PaulHannaMD @sandra_k910 @fouadchebib @TheLancet @GlomCon @kidneymo @Arvind__ Thank you Paul! ❤️

[Sol Carriazo, Neph. @Nefrontera]

@SaynaNorouzi @kidneymo @Arvind__ @GlomCon @TheLancet Thank you! ❤️

[Sandra Karanovic Stambuk @sandra_k910]

Our amazing Sol giving a talk on ADPKD based on her @TheLancet paper today at @GlomCon PKD fellowship

https://t.co/BqVFdKkgYB

[Noroژa | Niloufar Ebrahimi @n0r0zha]

Today at #PKDMDP @GlomCon we learned more about Polycystic Kidney Disease from Dr. Sol Carriazo @Nefrontera by reviewing her recent paper published in The Lancet @TheLancet

https://t.co/gg9c7ajulE

[Mohamed Hassanein 🇪🇬 محمد حسنين @kidneymo]

Renal cysts does NOT automatically equal ADPKD. So what is NOT ADPKD? Check out this slide by @Nefrontera from her lecture "ADPKD: An Updated Review."
@GlomCon PKD-MD Program

[Sol Carriazo, Neph. @Nefrontera]

Thank you so much for the invitation! @kidneymo @SaynaNorouzi ❤️

[Mohamed Hassanein 🇪🇬 محمد حسنين @kidneymo]

Thrilled to have @Nefrontera as our speaker today in the @GlomCon PKD-MD Program presenting an updated review on ADPKD based on her recently published review article in @TheLancet
Link to article: https://t.co/61Tr4hVpnG

[Sol Carriazo, Neph. @Nefrontera]

¡Muchas gracias por la invitación! Ha sido un honor poder compartir este espacio y conversar sobre un tema tan importante para la región. 💙🧬

[MaFer Zavala @Mafer_ZavalaM]

Cada vez el nefrólogo se debe de familiarizar más con la genética y conocer nuestra historia como Latinos🧬

La Dra @Nefrontera nos da un gran repaso en las genética de las enfermedades renales crónicas de causa desconocida en Latinoamérica.

@IMINmx
#Nefrología #ERC #Genética #EducaciónMédica #Nefropatología #Glomerulares #Podocitopatías

[GlomCon Ibero-LatinoAmérica @GlomConILA]

🚨No te pierdas este sábado el seminario:

☞ Glomerulopatías silenciosas: el poder diagnóstico de la atención primaria 👩🏻‍⚕️👨🏻‍⚕️

🗓️ 28/Marzo/26
🗣️ Dr. Enzo Vera
🕘 9 am CDMX

Zoom ID: 863 6358 3637
Pass: 343 190

#GlomConAmor #GlomConILA

[Fouad Chebib, MD, FASN @fouadchebib]

It was wonderful working with this amazing group of PKD experts to provide the US perspective on the global @goKDIGO ADPKD guidelines.
Check out this figure for chapter 4
@PKDFoundation @PkdResearch @MayoClinicNeph

[Matt Lanktree | #NephroGenetics @MattLanktree]

How can genomics and Mendelian randomization help drug targets traverse the "Valley of Death" in kidney research?
Please see and share our new paper:
https://t.co/r132NDUaUe

[Sayna Norouzi, MD, FASN @SaynaNorouzi]

Good morning, everyone! 😊 Kicking off the day moderating an incredible session by Dr. Hartung on PKD management in pediatrics and transition care at #PKDMDP @GlomCon #Nephrology #KidneyHealth #RareKidneyDiseases
@Nefrontera @kidneymo
@fouadchebib @pranavgarimella Dr. Dahl

[Sol Carriazo, Neph. @Nefrontera]

@SaynaNorouzi @MarioAlamilla @TheLancet @UHN @UHN_Research @UofT @UofTNephrology @PKDFoundation @torra_roser @FPuigvert Thank you so much Sayna!💜

[Sol Carriazo, Neph. @Nefrontera]

Honored to share our Review published in @TheLancet about ADPKD

Highlighting advances in genetics, imaging, and disease-modifying therapies.

Grateful to collaborate with such an exceptional team led by Dr. Y. Pei from @UHN, Dr. R. Torra, Dr. A. Ong and Dr. B. Mingyao

👇🏽